Antimicrobial Resistance

Antimicrobial resistance occurs when bacteria, fungi, viruses, and parasites mutate naturally over time and to resist the effects of medications that were once effective for treating them. This means that standard treatment options become ineffective, causing the infection to persist, which increases the risk of severe consequences to the patient. 

Antimicrobial stewardship (AMS) is a commitment to preserving antimicrobial efficacy for future generations through appropriate use of these treatments. The goal of antimicrobial stewardship initiatives is to ensure that the right antibiotic is given to the right patient at the right time, with the right dose and via the right route. In realistic terms, it is a multidisciplinary approach that aims to ensure that patients benefit from the most effective antimicrobial treatments while limiting the side effects and costs of unnecessary treatments.

bioMérieux is your trusted partner in today's healthcare systems. We provide a comprehensive diagnostics and expertise, enabling hospital laboratories to provide actionable evidence and insights to clinicians. Together, we'll work on improving patient outcomes and create more effective stewardship programs. 

Our end-to-end antimicrobial stewardship solution encompasses more than just traditional state-of-the-art lab technology. Because at bioMérieux we fully understand your AMS needs, our offer translates into three key areas where we help hospitals and labs better inform antimicrobial initiation, optimization, and discontinuation. 

Actionable Diagnostics

Diagnostic tools help clinicians determine timely and appropriate treatment, which help reduce the spread of drug-resistant infections. As the largest in vitro diagnostics company committed to antimicrobial stewardship, we help maximize the use of diagnostic solutions to detect, identify, and treat drug-resistant pathogens.

Advanced Analytics

We support healthcare systems in their efforts to deliver evidence-based clinical care with our software solutions that help to optimize efficiency and increase collaborative communication.

Collaborative Services

Improve lab efficiency and accelerate the medical and economic value of stewardship.

bioMérieux is taking a proactive, partnership-driven approach by creating the Antimicrobial Stewardship Centers of Excellence (COE) initiative to focus on delivering high-value solutions, expertise and service in AMS efforts in order to improve patient care.

In 2021, bioMérieux established the Antimicrobial Stewardship Centers of Excellence program to bring attention to the threat of antimicrobial resistance and to accelerate the impact that infectious diseases diagnostics have in facilitating antimicrobial stewardship and improve patient care. bioMérieux has formalized partnerships with 14 hospitals globally.

In North America, Tampa General Hospital and Henry Ford Health are two health systems that have received this Global Antimicrobial Stewardship Center of Excellence designation. Find out more as their team shares what this designation means to them.